QUIPT HOME MEDICAL CORP (QIPT) Stock Fundamental Analysis

NASDAQ:QIPT • CA74880P1045

3.61 USD
0 (0%)
Last: Feb 20, 2026, 08:00 PM
Fundamental Rating

3

QIPT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of QIPT have multiple concerns. QIPT shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year QIPT has reported negative net income.
  • QIPT had a positive operating cash flow in the past year.
  • In the past 5 years QIPT reported 4 times negative net income.
  • In the past 5 years QIPT always reported a positive cash flow from operatings.
QIPT Yearly Net Income VS EBIT VS OCF VS FCFQIPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M

1.2 Ratios

  • QIPT has a Return On Assets of -3.80%. This is in the lower half of the industry: QIPT underperforms 64.36% of its industry peers.
  • QIPT's Return On Equity of -10.57% is in line compared to the rest of the industry. QIPT outperforms 41.58% of its industry peers.
Industry RankSector Rank
ROA -3.8%
ROE -10.57%
ROIC N/A
ROA(3y)-2.55%
ROA(5y)-1.94%
ROE(3y)-6.5%
ROE(5y)-4.81%
ROIC(3y)N/A
ROIC(5y)N/A
QIPT Yearly ROA, ROE, ROICQIPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

1.3 Margins

  • Looking at the Gross Margin, with a value of 72.38%, QIPT belongs to the top of the industry, outperforming 88.12% of the companies in the same industry.
  • QIPT's Gross Margin has been stable in the last couple of years.
  • QIPT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.78%
GM growth 5Y-0.1%
QIPT Yearly Profit, Operating, Gross MarginsQIPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

2

2. Health

2.1 Basic Checks

  • QIPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • QIPT has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for QIPT has been increased compared to 5 years ago.
  • Compared to 1 year ago, QIPT has a worse debt to assets ratio.
QIPT Yearly Shares OutstandingQIPT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
QIPT Yearly Total Debt VS Total AssetsQIPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • QIPT has an Altman-Z score of 0.54. This is a bad value and indicates that QIPT is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.54, QIPT is not doing good in the industry: 74.26% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of QIPT is 4.32, which is a neutral value as it means it would take QIPT, 4.32 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 4.32, QIPT is doing good in the industry, outperforming 67.33% of the companies in the same industry.
  • A Debt/Equity ratio of 0.91 indicates that QIPT is somewhat dependend on debt financing.
  • QIPT has a Debt to Equity ratio of 0.91. This is comparable to the rest of the industry: QIPT outperforms 43.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 4.32
Altman-Z 0.54
ROIC/WACCN/A
WACC8.16%
QIPT Yearly LT Debt VS Equity VS FCFQIPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 1.04 indicates that QIPT should not have too much problems paying its short term obligations.
  • QIPT's Current ratio of 1.04 is on the low side compared to the rest of the industry. QIPT is outperformed by 69.31% of its industry peers.
  • QIPT has a Quick Ratio of 1.04. This is a bad value and indicates that QIPT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • QIPT has a worse Quick ratio (0.68) than 80.20% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 0.68
QIPT Yearly Current Assets VS Current LiabilitesQIPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

7

3. Growth

3.1 Past

  • QIPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -71.43%.
  • QIPT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.52%.
  • The Revenue has been growing by 27.58% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)9.52%
Revenue growth 3Y20.59%
Revenue growth 5Y27.58%
Sales Q2Q%31.96%

3.2 Future

  • QIPT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 103.14% yearly.
  • Based on estimates for the next years, QIPT will show a very strong growth in Revenue. The Revenue will grow by 33.45% on average per year.
EPS Next Y28.6%
EPS Next 2Y-6.88%
EPS Next 3Y103.14%
EPS Next 5YN/A
Revenue Next Year28.75%
Revenue Next 2Y14.48%
Revenue Next 3Y33.45%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
QIPT Yearly Revenue VS EstimatesQIPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
QIPT Yearly EPS VS EstimatesQIPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 -2

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for QIPT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QIPT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QIPT Price Earnings VS Forward Price EarningsQIPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

  • QIPT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. QIPT is cheaper than 89.11% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of QIPT indicates a rather cheap valuation: QIPT is cheaper than 93.07% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.98
EV/EBITDA 6.04
QIPT Per share dataQIPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as QIPT's earnings are expected to grow with 103.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.88%
EPS Next 3Y103.14%

0

5. Dividend

5.1 Amount

  • QIPT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

QUIPT HOME MEDICAL CORP

NASDAQ:QIPT (2/20/2026, 8:00:45 PM)

3.61

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-09
Earnings (Next)05-11
Inst Owners49.34%
Inst Owner Change-5.29%
Ins Owners16.51%
Ins Owner Change0%
Market Cap158.95M
Revenue(TTM)264.97M
Net Income(TTM)-10.67M
Analysts76.36
Price Target3.98 (10.25%)
Short Float %1.95%
Short Ratio0.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-37.27%
Min EPS beat(2)-135.32%
Max EPS beat(2)60.78%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.96%
Min Revenue beat(2)4.31%
Max Revenue beat(2)5.61%
Revenue beat(4)2
Avg Revenue beat(4)0.05%
Min Revenue beat(4)-9.06%
Max Revenue beat(4)5.61%
Revenue beat(8)2
Avg Revenue beat(8)-3.88%
Revenue beat(12)3
Avg Revenue beat(12)-3.06%
Revenue beat(16)3
Avg Revenue beat(16)-3.41%
PT rev (1m)1.39%
PT rev (3m)6.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-120%
EPS NY rev (1m)0%
EPS NY rev (3m)-218.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.6
P/FCF 5.98
P/OCF 4.26
P/B 1.57
P/tB N/A
EV/EBITDA 6.04
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)0.6
FCFY16.73%
OCF(TTM)0.85
OCFY23.49%
SpS6.02
BVpS2.29
TBVpS-0.83
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.8%
ROE -10.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.38%
FCFM 10.03%
ROA(3y)-2.55%
ROA(5y)-1.94%
ROE(3y)-6.5%
ROE(5y)-4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.78%
GM growth 5Y-0.1%
F-Score3
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 4.32
Debt/EBITDA 2.1
Cap/Depr 22.85%
Cap/Sales 4.06%
Interest Coverage N/A
Cash Conversion 85.67%
Profit Quality N/A
Current Ratio 1.04
Quick Ratio 0.68
Altman-Z 0.54
F-Score3
WACC8.16%
ROIC/WACCN/A
Cap/Depr(3y)22.45%
Cap/Depr(5y)27.1%
Cap/Sales(3y)4.11%
Cap/Sales(5y)4.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y28.6%
EPS Next 2Y-6.88%
EPS Next 3Y103.14%
EPS Next 5YN/A
Revenue 1Y (TTM)9.52%
Revenue growth 3Y20.59%
Revenue growth 5Y27.58%
Sales Q2Q%31.96%
Revenue Next Year28.75%
Revenue Next 2Y14.48%
Revenue Next 3Y33.45%
Revenue Next 5YN/A
EBIT growth 1Y-1136.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1993.49%
EBIT Next 3Y243.93%
EBIT Next 5YN/A
FCF growth 1Y-34.07%
FCF growth 3Y13.83%
FCF growth 5Y12.69%
OCF growth 1Y-21.31%
OCF growth 3Y12.69%
OCF growth 5Y21.85%

QUIPT HOME MEDICAL CORP / QIPT FAQ

Can you provide the ChartMill fundamental rating for QUIPT HOME MEDICAL CORP?

ChartMill assigns a fundamental rating of 3 / 10 to QIPT.


Can you provide the valuation status for QUIPT HOME MEDICAL CORP?

ChartMill assigns a valuation rating of 3 / 10 to QUIPT HOME MEDICAL CORP (QIPT). This can be considered as Overvalued.


Can you provide the profitability details for QUIPT HOME MEDICAL CORP?

QUIPT HOME MEDICAL CORP (QIPT) has a profitability rating of 2 / 10.


What is the financial health of QUIPT HOME MEDICAL CORP (QIPT) stock?

The financial health rating of QUIPT HOME MEDICAL CORP (QIPT) is 2 / 10.


What is the earnings growth outlook for QUIPT HOME MEDICAL CORP?

The Earnings per Share (EPS) of QUIPT HOME MEDICAL CORP (QIPT) is expected to grow by 28.6% in the next year.